What companies are IMNM's competitors?

Immunome, Inc. (IMNM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does IMNM compare to its peers?

The peer comparison table on this page shows Immunome, Inc. (IMNM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does IMNM operate in?

Immunome, Inc. (IMNM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

IMNM

Immunome, Inc.

NASDAQ·Biotechnology · Healthcare

$17.89$0.10−0.56%

After hours·$17.74−0.84%

Market cap$2.11B·Market closed·Oct 26 4:00 PM EDT

Frequently Asked Questions About IMNM

What companies are IMNM's competitors?: Immunome, Inc. (IMNM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IMNM compare to its peers?: The peer comparison table on this page shows Immunome, Inc. (IMNM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IMNM operate in?: Immunome, Inc. (IMNM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

IMNM

Immunome, Inc.

NASDAQ·Biotechnology · Healthcare

$17.89$0.10−0.56%

After hours·$17.74−0.84%

Market cap$2.11B·Market closed·Oct 26 4:00 PM EDT

Peers

Sort:


CLDXCLDXCelldex Therapeutics, Inc.	Celldex Therapeutics, Inc.	$29.50	$2.3B
SLSSLSSELLAS Life Sciences Group, Inc.	SELLAS Life Sciences Group, Inc.	$11.34	$2.3B
IMCRIMCRImmunocore Holdings plc	Immunocore Holdings plc	$31.28	$1.6B
IMTXIMTXImmatics N.V.	Immatics N.V.	$7.15	$1.1B
CRVSCRVSCorvus Pharmaceuticals, Inc.	Corvus Pharmaceuticals, Inc.	$10.45	$879.1M
AVBPAVBPArriVent BioPharma, Inc.	ArriVent BioPharma, Inc.	$15.36	$757.4M
IMMXIMMXImmix Biopharma, Inc.	Immix Biopharma, Inc.	$8.06	$668.2M
BCYCBCYCBicycle Therapeutics plc	Bicycle Therapeutics plc	$3.65	$254.8M
STROSTROSutro Biopharma, Inc.	Sutro Biopharma, Inc.	$8.89	$147.3M
MGNXMGNXMacroGenics, Inc.	MacroGenics, Inc.	$2.19	$139.5M

Frequently Asked Questions About IMNM

What companies are IMNM's competitors?: Immunome, Inc. (IMNM)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IMNM compare to its peers?: The peer comparison table on this page shows Immunome, Inc. (IMNM) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IMNM operate in?: Immunome, Inc. (IMNM) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.